Pub. Date : 2019 Mar-Apr
PMID : 30923740
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Each rat was administered either 10 mg/kg of exogenous clozapine-N-oxide (CNO) to inhibit DREADD-expressing cells or vehicle intraperitoneal followed by a test treatment with either 2-mg/kg ANG II or 3% HTN (1 ml/100-g bw, s.c.), twice per week for two separate treatment weeks. | clozapine N-oxide | biogenesis of lysosomal organelles complex 1 subunit 4 | Rattus norvegicus |